Literature DB >> 8641976

Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families.

H Kanno1, T Shuin, K Kondo, S Ito, M Hosaka, S Torigoe, S Fujii, Y Tanaka, I Yamamoto, I Kim, M Yao.   

Abstract

We analyzed deoxyribonucleic acids from blood samples of five Japanese von Hippel-Lindau (VHL) disease families (three familial cases, two new mutations) for the presence of VHL gene mutations by single-strand conformational polymorphism analysis and direct sequencing. Four of the five families showed germ line mutations in VHL gene, comprising 2 missense mutations, 1 deletion, and 1 splice-site mutation. Two families had VHL gene mutations at exon 1; 1 family at exon 3; and 1 family at the splice-site adjacent to exon 3. Presymptomatic patients were accurately diagnosed by these methods. However, one family did not show a VHL gene mutation in the germ line but showed a somatic mutation at exon 2 in the hemangioblastoma tissue. The consequence of the somatic mutation was a microdeletion leading to a frameshift mutation. Our study is the first report of VHL gene analyses of Japanese VHL disease families, and suggests that not only germ line mutation, but also somatic mutation can lead to development of a tumor associated with the VHL disease.

Entities:  

Mesh:

Year:  1996        PMID: 8641976      PMCID: PMC5921130          DOI: 10.1111/j.1349-7006.1996.tb00240.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

Authors:  T Hultman; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

4.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

5.  Cerebellar haemangioblastoma and von Hippel-Lindau disease.

Authors:  S M Huson; P S Harper; M D Hourihan; G Cole; R D Weeks; D A Compston
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

6.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

7.  Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis.

Authors:  P M Kessler; S P Vasavada; R R Rackley; T Stackhouse; F M Duh; F Latif; M I Lerman; B Zbar; B R Williams
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

8.  Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Authors:  F Chen; T Kishida; M Yao; T Hustad; D Glavac; M Dean; J R Gnarra; M L Orcutt; F M Duh; G Glenn
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; G E Farmer; J M Lamiell; J Haines; J W Yuen; D Collins; D Majoor-Krakauer
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

View more
  4 in total

1.  Software and database for the analysis of mutations in the VHL gene.

Authors:  C Béroud; D Joly; C Gallou; F Staroz; M T Orfanelli; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.

Authors:  S Cingoz; R B van der Luijt; E Kurt; M Apaydin; I Akkol; Mihriban Heval Ozgen
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

3.  Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.

Authors:  Gergely Losonczy; Ferenc Fazakas; György Pfliegler; István Komáromi; Erzsébet Balázs; Krisztina Pénzes; András Berta
Journal:  BMC Med Genet       Date:  2013-01-08       Impact factor: 2.103

4.  Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.

Authors:  M Yoshida; S Ashida; K Kondo; K Kobayashi; H Kanno; N Shinohara; N Shitara; T Kishida; S Kawakami; M Baba; I Yamamoto; M Hosaka; T Shuin; M Yao
Journal:  Jpn J Cancer Res       Date:  2000-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.